Abiopharma

🔍 HURLSTON MICHAEL E. (Executive)

Company: Lumentum Holdings Inc. (LITE)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 7,941 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 187,499.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 548 shares of Common Stock at $958.66 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 186,951.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, following vesting, one share of the Issuer's Common Stock. 1/3 of the shares shall vest one year from the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter on the 15th of November, February, May and August, subject to the Reporting Person continuing to be an employee through each such date, or as provided under the Issuer's 2025 Equity Incentive Plan.
• F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026.